About AqueSys
AqueSys is a company based in Aliso Viejo (United States) founded in 2006 was acquired by Allergan in September 2015.. AqueSys has raised $87.6 million across 4 funding rounds from investors including The Carlyle Group, Allergan and Accuitive Medical Ventures. AqueSys operates in a competitive market with competitors including Glaukos, Ivantis, Myra Vision, Transcend Medical and InnFocus, among others.
- Headquarter Aliso Viejo, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$87.6 M (USD)
in 4 rounds
-
Latest Funding Round
$43.6 M (USD), Series D
Jan 16, 2014
-
Investors
The Carlyle Group
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Allergan
(Sep 03, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AqueSys
AqueSys has successfully raised a total of $87.6M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $43.6 million completed in January 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $43.6M
-
First Round
First Round
(22 Jul 2008)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2014 | Amount | Series D - AqueSys | Valuation |
investors |
|
| May, 2012 | Amount | Debt – Conventional - AqueSys | Valuation |
investors |
|
| Jun, 2010 | Amount | Series C - AqueSys | Valuation | Longitude Capital , Rho Capital Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AqueSys
AqueSys has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include The Carlyle Group, Allergan and Accuitive Medical Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location | |
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AqueSys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AqueSys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aquesys Comparisons
Competitors of AqueSys
AqueSys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glaukos, Ivantis, Myra Vision, Transcend Medical and InnFocus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of implants to treat glaucoma
|
|
| domain | founded_year | HQ Location |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based devices for glaucoma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.
|
|
| domain | founded_year | HQ Location |
Glaucoma is treated via the implantable MicroShunt device in ophthalmology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aquesys
Frequently Asked Questions about AqueSys
When was AqueSys founded?
AqueSys was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Where is AqueSys located?
AqueSys is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.
Is AqueSys a funded company?
AqueSys is a funded company, having raised a total of $87.6M across 4 funding rounds to date. The company's 1st funding round was a Series C of $35M, raised on Jul 22, 2008.
What does AqueSys do?
AqueSys was founded in 2006 in Aliso Viejo, United States, as an ophthalmic company. Focus is placed on implantable devices to manage glaucoma. The XEN Gel Stent, a gelatin-based implant for intraocular pressure control, was developed and received CE Mark approval in Europe. Injection occurs via a preloaded device through a self-sealing incision. Acquisition by Allergan took place in 2015, with US approval pending at that time.
Who are the top competitors of AqueSys?
AqueSys's top competitors include Glaukos, Myra Vision and Avisi Technologies.
Who are AqueSys's investors?
AqueSys has 6 investors. Key investors include The Carlyle Group, Allergan, Accuitive Medical Ventures, Longitude Capital, and SV Health Investors.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.